Physician profile
John K Schlueter
NPI 1659385375
$809.00
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $47.07 · 2021: $223 · 2022: $128 · 2023: $187 · 2024: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $193.38 | 2022-2024 | Botox |
| Astellas Pharma US INC | $189.84 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $86.69 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $82.45 | 2023-2024 | Gemtesa |
| Urovant Sciences INC | $53.69 | 2022 | |
| Supernus Pharmaceuticals, INC. | $43.40 | 2019-2020 | |
| Pfizer INC. | $41.58 | 2019-2022 | |
| Smith+Nephew, INC. | $25.09 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $22.64 | 2019 | |
| Ferring Pharmaceuticals INC. | $20.82 | 2024 | Adstiladrin |
| Myovant Sciences INC. | $18.48 | 2022 | |
| Cook Medical LLC | $15.74 | 2023 | Cook |
| Accord Healthcare, INC. | $15.20 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schlueter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.